Trial with Tovaxin™ for Multiple Sclerosis
Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin™ for Multiple Sclerosis
Multiple Sclerosis Patients Benefit From High Dose, High Frequency Interferon Beta
Multiple Sclerosis Patients Benefit From High Dose, High Frequency Interferon Beta
Depression Not Related to Disease Modifying Therapy in Multiple Sclerosis
Depression Not Related to Disease Modifying Therapy in Multiple Sclerosis: Presented at ENS
Bonnie – Spinal Tap
Bonnie’s Lumbar Puncture (Spinal Tap)
NICE Recommends TYSABRI® for Use in Highly Active Relapsing Remitting Multiple Sclerosis
NICE Recommends TYSABRI® for Use in Highly Active Relapsing Remitting Multiple Sclerosis
The use of stem cells for the treatment of autoimmune diseases.
The use of stem cells for the treatment of autoimmune diseases.
Autoimmune diseases constitute a heterogeneous group of conditions commonly treated with anti-inflammatory, immunosuppressant, and immunomodulating drugs, with satisfactory results in most cases. Nevertheless, some patients become resistant to conventional therapy. The use of high doses of drugs in such cases results in the need for bone marrow reconstitution, a situation which has stimulated… read more »
placebo-controlled trial of natalizumab in relapsing MS.
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS.
Estrogen' Identified As Potential MS Drug—
Estrogen’ Identified As Potential MS Drug—
'CARS' (coherent anti-Stokes Raman scattering) imaging reveals clues to myelin damage
‘CARS’ (coherent anti-Stokes Raman scattering) imaging reveals clues to myelin damage
WEST LAFAYETTE, Ind. –
Purdue University
Response to Interferon Beta Therapy in a Cohort of Relapsing-remitting Multiple Sclerosis
Response to Interferon Beta Therapy in a Cohort of Relapsing-remitting Multiple Sclerosis
